Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03899077
Title Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP (SAVE)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Cancer Research Antwerp
Indications

prostate adenocarcinoma

Therapies

Triptorelin

Goserelin

Degarelix

Leuprolide

Apalutamide

Age Groups: senior | adult
Covered Countries BEL


No variant requirements are available.